Reuters
02 Oct 2026, 18:34 UTC · 2h ago
Owners of Brazil's Braskem finalizing counter proposal to $3 billion capital demand
Impact · against what's priced in
The news regarding Braskem's refusal to meet a $3 billion capital injection demand is potentially negative, but the impact cannot be precisely calibrated against the current price assumptions. Because there is no established priced-in reconstruction, it is unclear if the market has already discounted a funding gap or credit friction.
- BRKM5.SA−0.40
No priced-in read yet
- In context
The price's assumptions are unknown as no reconstruction is on file; however, the rejection of a $3bn capital demand creates a concrete funding gap and potential for credit rating downgrades.
Read from the article alone
Search tags
